151 related articles for article (PubMed ID: 25377726)
1. Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.
Theurl M; Schgoer W; Albrecht-Schgoer K; Lener D; Wolf D; Wolf M; Demetz E; Tymoszuk P; Tancevski I; Fischer-Colbrie R; Franz WM; Marschang P; Kirchmair R
Cardiovasc Res; 2015 Jan; 105(1):96-106. PubMed ID: 25377726
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
Schgoer W; Theurl M; Jeschke J; Beer AG; Albrecht K; Gander R; Rong S; Vasiljevic D; Egger M; Wolf AM; Frauscher S; Koller B; Tancevski I; Patsch JR; Schratzberger P; Piza-Katzer H; Ritsch A; Bahlmann FH; Fischer-Colbrie R; Wolf D; Kirchmair R
Circ Res; 2009 Nov; 105(10):994-1002. PubMed ID: 19797703
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy.
Theurl M; Lener D; Albrecht-Schgoer K; Beer A; Schgoer W; Liu Y; Stanzl U; Fischer-Colbrie R; Kirchmair R
FASEB J; 2018 Sep; 32(9):4815-4823. PubMed ID: 29913555
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-150 Modulates Ischemia-Induced Neovascularization in Atherosclerotic Conditions.
Desjarlais M; Dussault S; Dhahri W; Mathieu R; Rivard A
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):900-908. PubMed ID: 28254813
[TBL] [Abstract][Full Text] [Related]
6. Secretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularization.
Schgoer W; Theurl M; Albrecht-Schgoer K; Jonach V; Koller B; Lener D; Franz WM; Kirchmair R
PLoS One; 2013; 8(9):e74029. PubMed ID: 24086307
[TBL] [Abstract][Full Text] [Related]
7. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells.
Albrecht-Schgoer K; Schgoer W; Holfeld J; Theurl M; Wiedemann D; Steger C; Gupta R; Semsroth S; Fischer-Colbrie R; Beer AG; Stanzl U; Huber E; Misener S; Dejaco D; Kishore R; Pachinger O; Grimm M; Bonaros N; Kirchmair R
Circulation; 2012 Nov; 126(21):2491-501. PubMed ID: 23081990
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model.
Albrecht-Schgoer K; Barthelmes J; Schgoer W; Theurl M; Nardin I; Lener D; Gutmann C; Dünnhaupt S; Bernkop-Schnürch A; Kirchmair R
J Control Release; 2017 Mar; 250():1-8. PubMed ID: 28167285
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil increases endothelial progenitor cell function and improves ischemia-induced neovascularization in hypercholesterolemic apolipoprotein E-deficient mice.
Dussault S; Maingrette F; Ménard C; Michaud SE; Haddad P; Groleau J; Turgeon J; Perez G; Rivard A
Hypertension; 2009 Nov; 54(5):1043-9. PubMed ID: 19770400
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells.
Hardy B; Battler A; Weiss C; Kudasi O; Raiter A
Biochem Pharmacol; 2008 Feb; 75(4):891-9. PubMed ID: 18022603
[TBL] [Abstract][Full Text] [Related]
12. Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide.
Lefèvre J; Michaud SE; Haddad P; Dussault S; Ménard C; Groleau J; Turgeon J; Rivard A
FASEB J; 2007 Dec; 21(14):3845-52. PubMed ID: 17641150
[TBL] [Abstract][Full Text] [Related]
13. Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice.
Feng Y; Gordts SC; Chen F; Hu Y; Van Craeyveld E; Jacobs F; Carlier V; Feng Y; Zhang Z; Xu Q; Ni Y; De Geest B
Atherosclerosis; 2011 Feb; 214(2):271-8. PubMed ID: 20943224
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy with Pellino-1 improves perfusion and decreases tissue loss in Flk-1 heterozygous mice but fails in MAPKAP Kinase-2 knockout murine hind limb ischemia model.
Thirunavukkarasu M; Pradeep SR; Ukani G; Abunnaja S; Youssef M; Accorsi D; Swaminathan S; Lim ST; Parker V; Campbell J; Tipu Rishi M; Palesty JA; Maulik N
Microvasc Res; 2022 May; 141():104311. PubMed ID: 34999110
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.
Silvestre JS; Gojova A; Brun V; Potteaux S; Esposito B; Duriez M; Clergue M; Le Ricousse-Roussanne S; Barateau V; Merval R; Groux H; Tobelem G; Levy B; Tedgui A; Mallat Z
Circulation; 2003 Dec; 108(23):2839-42. PubMed ID: 14656923
[TBL] [Abstract][Full Text] [Related]
16. The Neuropeptide Secretoneurin Exerts a Direct Effect on Arteriogenesis In Vivo and In Vitro.
Liu W; Wang F; Zhao M; Fan Y; Cai W; Luo M
Anat Rec (Hoboken); 2018 Nov; 301(11):1917-1927. PubMed ID: 30288932
[TBL] [Abstract][Full Text] [Related]
17. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
18. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.
Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T
Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
